Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Pyridam Farma Tbk's other current liabilities for the quarter that ended in Mar. 2026 was Rp241,913 Mil.
PT Pyridam Farma Tbk's quarterly other current liabilities
increased
from Sep. 2025 (Rp246,176 Mil) to Dec. 2025 (Rp255,634 Mil) but then
declined
from Dec. 2025 (Rp255,634 Mil) to Mar. 2026 (Rp241,913 Mil).
PT Pyridam Farma Tbk's annual other current liabilities
increased
from Dec. 2023 (Rp49,929 Mil) to Dec. 2024 (Rp196,134 Mil) and
increased
from Dec. 2024 (Rp196,134 Mil) to Dec. 2025 (Rp255,634 Mil).
PT Pyridam Farma Tbk Other Current Liabilities Related Terms
PT Pyridam Farma Tbk Other Current Liabilities Historical Data
* Premium members only.
The historical data trend for PT Pyridam Farma Tbk's Other Current Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Pyridam Farma Tbk Other Current Liabilities Chart
PT Pyridam Farma Tbk Other Current Liabilities Calculation
The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.
What does a Other Current Liabilities of Rp241,913 Mil mean?
PT Pyridam Farma Tbk (ISX:PYFA) has a Other Current Liabilities of Rp241,913 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Pyridam Farma Tbk.
Is PT Pyridam Farma Tbk's Other Current Liabilities too high?
PT Pyridam Farma Tbk's current Other Current Liabilities is Rp241,913 Mil. Overall, PT Pyridam Farma Tbk has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Pyridam Farma Tbk's Other Current Liabilities compare to ZTS and UTHR?
PT Pyridam Farma Tbk's Other Current Liabilities of Rp241,913 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on PT Pyridam Farma Tbk. PT Pyridam Farma Tbk's current Other Current Liabilities is Rp241,913 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Pyridam Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk (ISX:PYFA) is currently considered Fairly Valued. The stock's GF Value™ is Rp211.75, compared to a current price of Rp202.00 — trading 4.6% below its estimated fair value. The current Other Current Liabilities is Rp241,913 Mil. PT Pyridam Farma Tbk's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For PT Pyridam Farma Tbk (ISX:PYFA), the current Other Current Liabilities is Rp241,913 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Pyridam Farma Tbk (ISX:PYFA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Pyridam Farma Tbk stock appears to be undervalued.
The current stock price of Rp202.00 is trading 4.6% below its estimated GF Value™ of Rp211.75.
GuruFocus considers PT Pyridam Farma Tbk to be Fairly Valued.
Key valuation signals for ISX:PYFA:
Other Current Liabilities: Rp241,913 Mil
GF Value™: Rp211.75 vs. price of Rp202.00 (4.6% below fair value)
No single metric tells the full story. See the ISX:PYFA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Pyridam Farma Tbk is engaged in the production and development of pharmaceutical medicines and the trading of medical equipment. It manufactures products namely Antibiotics, Vitamins, Supplements, and Traditional herbal care. It operates through two segments namely Pharmaceutical products, Esthetics, and Toll manufacturing services; and Medical equipment Products segment. The company derives maximum revenue from Pharmaceutical products, Esthetics, and Toll manufacturing services. The company's products include consumer health, Derma, prescription, and biomedilab.
65GF Score
Get the complete analysis for ISX:PYFA
Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PYFA has been successfully added to your 
